Technical Description
The present invention relates to a parenteral or an intravenous micro suspension of barium containing bioactive glass for treating cerebral ischemic reperfusion injury.
Problems Addressed
- High Toxicity
- Ischemic Stroke Damage
- Platelet Cohesion
- Thrombin Production
- Increased Formulation Strength Required
- Limited Efficiency of Existing Treatments
Tech Features
- Low Toxicity
- Anti-Thrombotic Properties
- Negligible Hemolytic Activity
- Cerebral Ischemic Reperfusion Treatment
- Anti-Platelet Activities
- Therapeutic Applications
Target Audience
- Medical and Healthcare Sector
- Pharmaceutical Industry
- Medical Device Manufacturing Industry
- Public Health Secto
- Research & Development
Tech ID: P35-1355 TRL 3 Patent Status: Granted Available For Exclusive and Non-exclusive License
